CTSNet Podcasts podcast

The Beat With Joel Dunning Ep. 138: CTSNet Summarized—The Best of 2025

0:00
30:01
15 Sekunden vorwärts
15 Sekunden vorwärts

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning reflects on the most popular content of 2025 on CTSNet.

Chapters

00:00 Intro

02:15 Top Interview

03:52 Top Webinar

05:23 Top Clinical Video

06:24 Top JANS Article

07:01 Top Video Series

08:02 Top Contributor

08:59 Top Cardiac Procedures

12:14 Top Podcasts

17:02 JANS 1, Doctor Story

21:28 JANS 2, Ex Vivo Heart Perfusion

22:41 JANS 3, PCI vs CABG

24:04 JANS 4, NEOpredict-Lung

25:29 2026 Plans

He discusses the top interview, the most popular webinar, and reveals the leading CTSNet contributor of the year. He also highlights the most-read JANS article, the most viewed CTSNet series, the top clinical videos in cardiac surgery, and the leading podcast episodes of 2025 from both The Beat and The Atrium. Additionally, he shares key statistics about CTSNet, including website viewership, YouTube subscribers, and listener demographics.  

Joel also highlights recent JANS articles on if ex vivo heart perfusion offsets ischemic penalties with six-hour or greater preservation in adult donation after brain death heart transplantation, an impactful article titled “This Man Saved My Life—I Live by His Example,” the long-term outcomes for women with chronic coronary artery disease after percutaneous coronary intervention vs coronary artery bypass grafting, and the long-term outcomes of preoperative nivolumab with or without relatlimab in patients with resectable non-small-cell lung cancer (NEOpredict-Lung).   

In addition, Joel outlines CTSNet’s goals and initiatives to look forward to in 2026. Before closing, he highlights upcoming events in CT surgery.   

JANS Items Mentioned 

1.)  Ex Vivo Heart Perfusion Offsets Ischemic Penalties With ≥6-Hour Preservation in Adult Donation-After-Brain-Death Heart Transplantation 

2.) This Man Saved My Life—I Live by His Example 

3.) Women With Chronic Coronary Artery Disease: Long-Term Outcomes After Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting 

4.) Long-Term Outcomes of Preoperative Nivolumab With or Without Relatlimab in Patients With Resectable Non-Small-Cell Lung Cancer (NEOpredict-Lung) 

CTSNet Content Mentioned 

1.) CTSNet Summarized—Most Popular Content of 2025 

2.) CTSNet Summarized—Most Popular Podcast Episodes of 2025 

3.) CTSNet Summarized—Top Cardiac Procedure Videos of 2025  

Other Items Mentioned 

1.) All CTSNet Summarized Content  

2.) 2025 CTSNet Recruitment Guide  

3.) Career Center  

4.) CTSNet Events Calendar 

Disclaimer

The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Weitere Episoden von „CTSNet Podcasts“